RemSleep Holdings (RMSL) Shareholder's Equity Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | RemSleep Holdings | - | - | -7,636.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.29% |
| Sep 30, 2025 | 18.63% |
| Jun 30, 2025 | 16.66% |
| Mar 31, 2025 | 17.66% |
| Dec 31, 2024 | 18.47% |
| Sep 30, 2024 | 22.02% |
| Jun 30, 2024 | 20.44% |
| Mar 31, 2024 | 21.11% |
| Dec 31, 2023 | 29.23% |
| Sep 30, 2023 | 31.68% |
| Jun 30, 2023 | 39.74% |
| Mar 31, 2023 | 54.09% |
| Dec 31, 2022 | 49.40% |
| Sep 30, 2022 | 58.98% |
| Jun 30, 2022 | 63.85% |
| Mar 31, 2022 | 68.56% |
| Dec 31, 2021 | 56.21% |
| Sep 30, 2021 | 44.22% |
| Jun 30, 2021 | -15.24% |
| Mar 31, 2021 | -17.88% |
| Dec 31, 2020 | -19.85% |
| Sep 30, 2020 | -13.34% |
| Jun 30, 2020 | -17.92% |
| Mar 31, 2020 | -23.45% |
| Dec 31, 2019 | -125.28% |
| Sep 30, 2019 | 23.48% |
| Jun 30, 2019 | 20.67% |
| Mar 31, 2019 | 21.82% |
| Dec 31, 2018 | 30.06% |
| Sep 30, 2018 | 21.22% |
| Jun 30, 2018 | 24.83% |
| Mar 31, 2018 | 16.61% |
| Dec 31, 2017 | 6.98% |
| Sep 30, 2017 | 16.08% |
| Jun 30, 2017 | -55.06% |
| Mar 31, 2017 | -130.49% |
| Dec 31, 2016 | -98.76% |
| Sep 30, 2016 | -99.89% |
| Jun 30, 2016 | -99.86% |
| Dec 31, 2015 | -103.58% |